Literature DB >> 15829423

Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.

Daniela Trinca Bertazzi1, Ana Isabel de Assis-Pandochi, Vinicius Luis Talhaferro, Ana Elisa Caleiro Seixas Azzolini, Luciana Simon Pereira Crott, Eliane Candiani Arantes.   

Abstract

The scorpion Tityus serrulatus is considered one of the most dangerous species in Brazil. Its venom evokes an inflammatory response, although the exact mechanism of this effect is still unknown. The aim of the present study was to investigate the effect of Tityus serrulatus venom (TsV) on the complement system (CS) and on leukocyte recruitment. Complement consumption by TsV was evaluated using in vitro hemolytic assays, immunoelectrophoresis and two-dimensional immunoelectrophoresis of complement components (factor B and C3). In order to evaluate neutrophil migration induced in normal human serum (NHS) in the presence of TsV, in vitro chemotaxis assays were performed using the Boyden chamber model. In vitro TsV induced a concentration- and time-dependent reduction in hemolytic activity of the classical/lectin and alternative complement pathways, with samples of 43.0 microg and 43.4 microg, respectively, inhibiting 50% of the lytic activity. Alterations in C3 and factor B electrophoretic mobility after incubation of NHS with TsV, were identical to those obtained with zymosan (positive control). Incubation of NHS with TsV induced neutrophil chemotaxis similar to that observed with zymosan-activated serum. Our results show that TsV activates the CS, leading to factor B and C3 cleavage, to reduction of serum lytic activity and generation of complement chemotactic factors. Therefore, CS may play an important role in the inflammatory response observed upon scorpion envenomation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829423     DOI: 10.1016/j.intimp.2005.02.007

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor.

Authors:  Fatah Chérifi; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

2.  Effect of purified Russell's viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats.

Authors:  Montamas Suntravat; Mariem Yusuksawad; Amornpun Sereemaspun; John C Pérez; Issarang Nuchprayoon
Journal:  Toxicon       Date:  2011-06-16       Impact factor: 3.033

3.  Bothrops snake venoms and their isolated toxins, an L-amino acid oxidase and a serine protease, modulate human complement system pathways.

Authors:  Lorena Rocha Ayres; Alex Dos Reis Récio; Sandra Mara Burin; Juliana Campos Pereira; Andrea Casella Martins; Suely Vilela Sampaio; Fabíola Attié de Castro; Luciana Simon Pereira-Crott
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

4.  Biological characterization of compounds from Rhinella schneideri poison that act on the complement system.

Authors:  Fernando A P Anjolette; Flávia P Leite; Karla C F Bordon; Ana Elisa C S Azzolini; Juliana C Pereira; Luciana S Pereira-Crott; Eliane C Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

Review 5.  Scorpion venom components as potential candidates for drug development.

Authors:  Ernesto Ortiz; Georgina B Gurrola; Elisabeth Ferroni Schwartz; Lourival D Possani
Journal:  Toxicon       Date:  2014-11-26       Impact factor: 3.033

6.  Scorpion peptides: potential use for new drug development.

Authors:  Bennasr Hmed; Hammami Turky Serria; Zeghal Khaled Mounir
Journal:  J Toxicol       Date:  2013-06-15

7.  A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.

Authors:  Isadora Maria Villas Boas; Giselle Pidde-Queiroz; Fabio Carlos Magnoli; Rute M Gonçalves-de-Andrade; Carmen W van den Berg; Denise V Tambourgi
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.